Singapore's multibillion dollar gamble

Singapore's multibillion dollar gamble

Figure 1Biopolis, Singapore's futuristic research hub.How does a country one-fourth the size of Rhode Island with little history in biomedical science become one of the world's biomedical research giants? The answer: with a pile of money and a large dose of chutzpah. Since 2000, Singapore...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of experimental medicine 2006-05, Vol.203 (5), p.1139-1142
1. Verfasser: Van Epps, Heather L
Format: Artikel
Sprache:eng
Schlagworte:
Biomedical Research - economics
Biomedical Research - organization & administration
Singapore
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1142
container_issue 5
container_start_page 1139
container_title The Journal of experimental medicine
container_volume 203
creator Van Epps, Heather L
description Figure 1Biopolis, Singapore's futuristic research hub.How does a country one-fourth the size of Rhode Island with little history in biomedical science become one of the world's biomedical research giants? The answer: with a pile of money and a large dose of chutzpah. Since 2000, Singapore has dumped more than US$2 billion into developing a biomedical research industry-from scratch. Is the gamble paying off?
doi_str_mv 10.1084/jem.20060895
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2121196</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67980004</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-1ddffad50637b75b94a9611e4a8343e7482fbf7d2f3eecd2bf07469a32644ca33</originalsourceid><addsrcrecordid>eNpVkElPwzAQRi0EoqVw44x6KhdSxku8XJBQxSZV4gCcLSexiysnKXaCxL8nqGU7zWGevm_mIXSKYY5Bssu1recEgINU-R4a45xBpnIq99EYgJAMA4gROkppDYAZy_khGmEugCkux2j25JuV2bTRnqdp3YfOFz4E3zbTqg3BxOnK1EWwx-jAmZDsyW5O0MvtzfPiPls-3j0srpdZSSXpMlxVzpkqB05FIfJCMaM4xpYZSRm1gkniCicq4qi1ZUUKB4JxZSjhjJWG0gm62uZu-qK2VWmbLpqgN9HXJn7o1nj9f9P4V71q3zXBBGPFh4DZLiC2b71Nna59Ku3wSmPbPmkulAQANoAXW7CMbUrRup8SDPpLrB7E6m-xA37297BfeGeSfgJi2HRp</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67980004</pqid></control><display><type>article</type><title>Singapore's multibillion dollar gamble</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Van Epps, Heather L</creator><creatorcontrib>Van Epps, Heather L</creatorcontrib><description>Figure 1Biopolis, Singapore's futuristic research hub.How does a country one-fourth the size of Rhode Island with little history in biomedical science become one of the world's biomedical research giants? The answer: with a pile of money and a large dose of chutzpah. Since 2000, Singapore has dumped more than US$2 billion into developing a biomedical research industry-from scratch. Is the gamble paying off?</description><identifier>ISSN: 0022-1007</identifier><identifier>EISSN: 1540-9538</identifier><identifier>DOI: 10.1084/jem.20060895</identifier><identifier>PMID: 16704968</identifier><language>eng</language><publisher>United States: The Rockefeller University Press</publisher><subject>Biomedical Research - economics ; Biomedical Research - organization &amp; administration ; Singapore</subject><ispartof>The Journal of experimental medicine, 2006-05, Vol.203 (5), p.1139-1142</ispartof><rights>Copyright © 2006, The Rockefeller University Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c382t-1ddffad50637b75b94a9611e4a8343e7482fbf7d2f3eecd2bf07469a32644ca33</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16704968$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Van Epps, Heather L</creatorcontrib><title>Singapore's multibillion dollar gamble</title><title>The Journal of experimental medicine</title><addtitle>J Exp Med</addtitle><description>Figure 1Biopolis, Singapore's futuristic research hub.How does a country one-fourth the size of Rhode Island with little history in biomedical science become one of the world's biomedical research giants? The answer: with a pile of money and a large dose of chutzpah. Since 2000, Singapore has dumped more than US$2 billion into developing a biomedical research industry-from scratch. Is the gamble paying off?</description><subject>Biomedical Research - economics</subject><subject>Biomedical Research - organization &amp; administration</subject><subject>Singapore</subject><issn>0022-1007</issn><issn>1540-9538</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkElPwzAQRi0EoqVw44x6KhdSxku8XJBQxSZV4gCcLSexiysnKXaCxL8nqGU7zWGevm_mIXSKYY5Bssu1recEgINU-R4a45xBpnIq99EYgJAMA4gROkppDYAZy_khGmEugCkux2j25JuV2bTRnqdp3YfOFz4E3zbTqg3BxOnK1EWwx-jAmZDsyW5O0MvtzfPiPls-3j0srpdZSSXpMlxVzpkqB05FIfJCMaM4xpYZSRm1gkniCicq4qi1ZUUKB4JxZSjhjJWG0gm62uZu-qK2VWmbLpqgN9HXJn7o1nj9f9P4V71q3zXBBGPFh4DZLiC2b71Nna59Ku3wSmPbPmkulAQANoAXW7CMbUrRup8SDPpLrB7E6m-xA37297BfeGeSfgJi2HRp</recordid><startdate>20060515</startdate><enddate>20060515</enddate><creator>Van Epps, Heather L</creator><general>The Rockefeller University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20060515</creationdate><title>Singapore's multibillion dollar gamble</title><author>Van Epps, Heather L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-1ddffad50637b75b94a9611e4a8343e7482fbf7d2f3eecd2bf07469a32644ca33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Biomedical Research - economics</topic><topic>Biomedical Research - organization &amp; administration</topic><topic>Singapore</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Van Epps, Heather L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of experimental medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Van Epps, Heather L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Singapore's multibillion dollar gamble</atitle><jtitle>The Journal of experimental medicine</jtitle><addtitle>J Exp Med</addtitle><date>2006-05-15</date><risdate>2006</risdate><volume>203</volume><issue>5</issue><spage>1139</spage><epage>1142</epage><pages>1139-1142</pages><issn>0022-1007</issn><eissn>1540-9538</eissn><abstract>Figure 1Biopolis, Singapore's futuristic research hub.How does a country one-fourth the size of Rhode Island with little history in biomedical science become one of the world's biomedical research giants? The answer: with a pile of money and a large dose of chutzpah. Since 2000, Singapore has dumped more than US$2 billion into developing a biomedical research industry-from scratch. Is the gamble paying off?</abstract><cop>United States</cop><pub>The Rockefeller University Press</pub><pmid>16704968</pmid><doi>10.1084/jem.20060895</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1007
ispartof The Journal of experimental medicine, 2006-05, Vol.203 (5), p.1139-1142
issn 0022-1007
1540-9538
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2121196
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Biomedical Research - economics
Biomedical Research - organization & administration
Singapore
title Singapore's multibillion dollar gamble
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T19%3A54%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Singapore's%20multibillion%20dollar%20gamble&rft.jtitle=The%20Journal%20of%20experimental%20medicine&rft.au=Van%20Epps,%20Heather%20L&rft.date=2006-05-15&rft.volume=203&rft.issue=5&rft.spage=1139&rft.epage=1142&rft.pages=1139-1142&rft.issn=0022-1007&rft.eissn=1540-9538&rft_id=info:doi/10.1084/jem.20060895&rft_dat=%3Cproquest_pubme%3E67980004%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67980004&rft_id=info:pmid/16704968&rfr_iscdi=true